🔴 Procter & Gamble is trading 3.6% down today after missing organic sales estimates and issuing weak FY26 guidance

Procter & Gamble is trading at $143.47 (3.6% down) after reporting Q4 organic sales that missed analyst forecasts despite a slight earnings beat.

• Organic sales were flat for the quarter, falling short of the 3% growth expected by analysts.
• The company issued a disappointing fiscal 2026 outlook, citing weaker-than-expected organic sales assumptions.
• Investors are prioritizing the lack of top-line momentum over the headline EPS beat, pressuring the stock in early trading.